Jeremy Gowler's professional background is in the commercial side of the vaccines and pharmaceutical industry. He currently holds the role of Global Head of Commercial for the Biopharmaceutical business of Sandoz (a division of Novartis) and resides with his family in Switzerland.
Mr. Gowler started his career in the pharmaceutical industry in 2002 with Novartis as a medical representative. He progressed through roles of increasing responsibility with Novartis in the areas of marketing, sales, medical affairs and operations in Canada, the US and in Switzerland until his departure in 2014. Mr. Gowler then joined a private equity backed biotechnology company called PaxVax in California, which was focused on developing and commercializing specialty human vaccines. He held the role of VP, Global Commercial at PaxVax. PaxVax was sold to Emergent Biosolutions in 2018, where Mr. Gowler became VP of Global Commercial for Emergent's vaccines business unit until his departure for Sandoz in 2020.
Mr. Gowler holds a BSc with a double major in Biology and Environmental Studies from the University of Victoria and a Dipl T in Marketing Management from the British Columbia Institute of Technology.